Gelteq Limited (GELS)
NasdaqCM: GELS
· Real-Time Price · USD
0.56
-0.01 (-1.75%)
At close: Aug 28, 2026, 3:51 PM
0.52
-6.30%
After-hours: 6:52 PM
The price, the headline numbers and the latest news, in one place.
Gelteq Limited (GELS) Stock Price, Analysis & Data
-1.75% (1D)
| Bid | 0.39 |
| Market Cap | 5.95M |
| Revenue (ttm) | 471.8K |
| Net Income (ttm) | -7.08M |
| n/a | |
| -0.51 | |
| n/a | |
| n/a | |
| P/B (ttm) | 0.62 |
| P/S (ttm) | 12.61 |
| Earnings Date | n/a |
| Ask | 0.74 |
| Volume | 11,404 |
| Avg. Volume (20D) | 3,677,437 |
| Open | 0.57 |
| Previous Close | 0.57 |
| Day's Range | 0.53 - 0.57 |
| 52-Week Range | 0.39 - 2.02 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About GELS
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia....
Sector Healthcare
IPO Date Oct 29, 2024
Employees 7
Stock Exchange NasdaqCM
Ticker Symbol GELS
Website https://www.gelteq.com
Financial Performance
In 2025, Gelteq's revenue was 165.65K, an increase of undefined% compared to the previous year's 0. Earnings were -6.65M, an increase of 87.4%.
Financial Statements